Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers With ADHD
Brief Summary: The objective of this study is to evaluate whether Osmotic-Release Methylphenidate (OROS MPH), relative to placebo, increases the effectiveness of standard smoking treatment (i.e., nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence for smokers with Attention Deficit Hyperactivity Disorder (ADHD).


Options:
A: Arm Label: Standard Care plus Wellness Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Wellness Program | Arm Label: Standard Care plus Exercise Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Aerobic Exercise | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Treatment; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Wellness Program; Assigned to Arm(s): Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise; Assigned to Arm(s): Standard Care plus Exercise Program
B: Arm Label: CPT+ICSC; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy (CPT), Drug: Bupropion, Drug: nicotine replacement therapy (NRT), Behavioral: Integrated Care for Smoking Cessation (ICSC), Behavioral: smokefreeVET | Arm Label: ICSC only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion, Drug: nicotine replacement therapy (NRT), Behavioral: Integrated Care for Smoking Cessation (ICSC), Behavioral: smokefreeVET | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy (CPT); Assigned to Arm(s): CPT+ICSC | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): CPT+ICSC, ICSC only | Intervention Type: DRUG; Name: nicotine replacement therapy (NRT); Assigned to Arm(s): CPT+ICSC, ICSC only | Intervention Type: BEHAVIORAL; Name: Integrated Care for Smoking Cessation (ICSC); Assigned to Arm(s): CPT+ICSC, ICSC only | Intervention Type: BEHAVIORAL; Name: smokefreeVET; Assigned to Arm(s): CPT+ICSC, ICSC only
C: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app
D: Arm Label: Osmotic-Release Methylphenidate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Osmotic-Release Methylphenidate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Osmotic-Release Methylphenidate; Assigned to Arm(s): Osmotic-Release Methylphenidate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D